Sequential Combination of FLAM and Venetoclax plus Azacitidine to Bridge to Cord Blood Transplantation in a Patient with Primary Induction Failure Acute Myeloid Leukemia

Venetoclax (VEN) is an oral B-cell lymphoma-2 (BCL-2) inhibitor that has been widely used to treat various hematological disorders. Recent studies have demonstrated that VEN in combination with fludarabine-enhanced high-dose cytarabine (FLA) is effective for treating relapsed or refractory acute mye...

Descripción completa

Detalles Bibliográficos
Autores principales: Murakami, Hiroyuki, Matsuoka, Ken-ichi, Asano, Takeru, Moriyama, Takashi, Matsumura, Akifumi, Fujiwara, Hideaki, Asada, Noboru, Ennishi, Daisuke, Nishimori, Hisakazu, Fujii, Keiko, Fujii, Nobuharu, Toji, Tomohiro, Yoshino, Tadashi, Maeda, Yoshinobu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830285/
https://www.ncbi.nlm.nih.gov/pubmed/36636684
http://dx.doi.org/10.1159/000526697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830285/
https://www.ncbi.nlm.nih.gov/pubmed/36636684
http://dx.doi.org/10.1159/000526697

Ejemplares similares